FindTrial
Sign In

GENETICS IN HEART ATTACK

GENETIC STUDY OF NUCLEAR FACTOR KAPPA B1 GENE POLYMORPHISM IN ACUTE CORONARY SYNDROME

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/052408
Enrollment
87
Registered
2023-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I219- Acute myocardial infarction, unspecified

Interventions

None listed

Sponsors

BLDE (DEEMED TO BE UNIVERSITY)
Lead Sponsor
Dr AMRUTA SUBHASH MHASKE
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS ADMITTED WITH ACUTE CORONARY SYNDROME

Exclusion criteria

Exclusion criteria: PATIENTS WITH VALVULAR HEART DISEASE PATIENTS WITH CARDIOMYOPATHY PATENTIS WITH CONGENITAL HEART DISEASE

Design outcomes

Primary

MeasureTime frame
TO IDENTIFY THE INDIVIDUAL RISK OF NF KAPPA B1 GENE MUTATION IN PATIENTS WITH ACUTE CORONARY SYNDROMETimepoint: 12 MONTHS—

Secondary

MeasureTime frame
BY EMPLOYING THE STUDYS COLLECTED DATA FOR SCREENING GENERAL POPULATION WHO ARE AT RISK OF ACUTE CORONARY SYNDROME, INTERVENING EARLIEST IN SUCH INDIVIDUALS WILL AID IN REDUCING THE BURDEN OF DISEASE IN TERMS OF MORBIDITY AND MORTALITY OF DISEASE WHEREAS STUDY WILL BE HELPFUL FOR DEVELOPMENT OF BIOMARKERS TO THE CLINICIAN AND THE COMMUNITY.Timepoint: 12 MONTHS—

Countries

India

Contacts

Public ContactDr BADIGER SHARANABASAWAPPA

BLDE (DEEMED TO BE UNIVERSITY)

sharanrb@rediffmail.com09448434927

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026